The PRKDC gene encoding DNA-PKcs is a critical component of the DNA damage repair (DDR) pathway, and mutations in the tumor DDR pathway can serve as important biomarkers for a response to checkpoint-based immunotherapies. This evidence concerns the gene PRKDC and neoplasm.